Iridex (IRIX) Net Cash Flow Growth (3y) (2014 - 2026)
Iridex (IRIX) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 129.29% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -48.90% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -65.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | 20.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 20.40% |
| Jan 3, 2026 | 31.47% |
| Sep 27, 2025 | 18.04% |
| Jun 28, 2025 | 46.33% |
| Mar 29, 2025 | 51.69% |
| Dec 28, 2024 | -28.36% |
| Mar 30, 2024 | -28.08% |
| Sep 30, 2023 | -91.01% |
| Jul 1, 2023 | -64.48% |
| Apr 1, 2023 | -23.22% |
| Dec 31, 2022 | -86.00% |
| Oct 1, 2022 | 7.28% |
| Jul 2, 2022 | -21.77% |
| Apr 2, 2022 | 6.88% |
| Jan 1, 2022 | 94.89% |
| Apr 3, 2021 | 92.04% |
| Sep 26, 2020 | 30.18% |
| Jun 27, 2020 | -12.21% |
| Mar 28, 2020 | -150.51% |
| Dec 28, 2019 | -26.38% |